×
Telesis Bio Income Taxes 2021-2024 | TBIO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Telesis Bio income taxes from 2021 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
View More
Telesis Bio Income Taxes 2021-2024 | TBIO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Telesis Bio income taxes from 2021 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$153.4B
Gilead Sciences (GILD)
$121.1B
Bristol Myers Squibb (BMY)
$119.6B
Vertex Pharmaceuticals (VRTX)
$118.9B
CSL (CSLLY)
$83.5B
Regeneron Pharmaceuticals (REGN)
$74B
GSK (GSK)
$73.1B
Argenex SE (ARGX)
$39.8B
Alnylam Pharmaceuticals (ALNY)
$35B
BioNTech SE (BNTX)
$29.7B
BeiGene (ONC)
$22B
Illumina (ILMN)
$21.1B
Biogen (BIIB)
$21B
Moderna (MRNA)
$15.2B
Incyte (INCY)
$14.3B
Insmed (INSM)
$13.7B
Intra-Cellular Therapies (ITCI)
$13.5B
Genmab (GNMSF)
$13B
Genmab (GMAB)
$13B
BioMarin Pharmaceutical (BMRN)
$12.1B
Bio-Techne Corp (TECH)
$11.7B
Vaxcyte (PCVX)
$11B
Sarepta Therapeutics (SRPT)
$10.9B
Swedish Orphan Biovitrum (BIOVF)
$10.9B
Exact Sciences (EXAS)
$10.4B
Bio-Rad Laboratories (BIO.B)
$10B
QIAGEN (QGEN)
$9.9B
Exelixis (EXEL)
$9.5B
Repligen (RGEN)
$9.3B
Roivant Sciences (ROIV)
$8.1B